In a meta-analysis of lung cancer involving 22,719 patients, it was found that the lower the Hb level, the shorter the OS of NSCLC or SCLC patients, indicating that reduced Hb levels were significantly associated with shorter OS in lung cancer patients [20]. This evidence concerns the gene GSTM1 and non-small cell lung carcinoma.